Loading…
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities in Alabama, Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Tennessee, Texas, Utah, Washington, Wisconsin, and Wyoming. The Company was incorporated in 2019 and is headquartered in Eagle, Idaho.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $948M | $61M | $30M | $36M | 8.9% | 36.3% | 31.1% |
| 2024 | $695M | $44M | $23M | $30M | 7.7% | 27.6% | 68.6% |
| 2023 | $545M | $31M | $13M | $25M | 9.5% | 15.1% | 101.4% |
| 2022 | $473M | $18M | $7M | $-5M | 5.5% | - | - |
| 2021 | - | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total Revenue | - | 473.24 | 544.89 | 695.24 | 947.70 |
| Operating Revenue | - | 473.24 | 544.89 | 695.24 | 947.70 |
| Cost Of Revenue | - | 414.66 | 477.86 | 601.48 | 817.20 |
| Gross Profit | - | 58.58 | 67.04 | 93.76 | 130.50 |
| Operating Expense | - | 38.88 | 41.80 | 56.33 | 79.61 |
| Selling General And Administration | - | 33.98 | 36.67 | 50.21 | 71.08 |
| Total Expenses | - | 453.54 | 519.65 | 657.81 | 896.82 |
| Operating Income | - | 19.70 | 25.24 | 37.43 | 50.89 |
| Total Operating Income As Reported | - | 12.74 | 25.17 | 38.12 | 51.89 |
| EBITDA | - | 17.61 | 30.64 | 44.44 | 60.85 |
| Normalized EBITDA | - | 24.57 | 30.71 | 43.76 | 59.85 |
| EBIT | - | 12.71 | 25.51 | 38.32 | 52.31 |
| Interest Expense | - | 3.82 | 5.92 | 6.96 | 6.68 |
| Net Interest Income | - | -3.82 | -5.92 | -6.96 | -6.68 |
| Other Non Operating Income Expenses | - | -0.03 | 0.34 | 0.21 | 0.42 |
| Other Income Expense | - | -7 | 0.27 | 0.89 | 1.42 |
| Interest Expense Non Operating | - | 3.82 | 5.92 | 6.96 | 6.68 |
| Net Non Operating Interest Income Expense | - | -3.82 | -5.92 | -6.96 | -6.68 |
| Pretax Income | - | 8.89 | 19.58 | 31.37 | 45.63 |
| Tax Provision | - | 1.65 | 5.67 | 7.03 | 11.87 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | -1.29 | -0.02 | 0.15 | 0.26 |
| Net Income Continuous Operations | - | 7.24 | 13.91 | 24.34 | 33.76 |
| Net Income From Continuing And Discontinued Operation | - | 6.64 | 13.38 | 22.56 | 29.58 |
| Net Income From Continuing Operation Net Minority Interest | - | 6.64 | 13.38 | 22.56 | 29.58 |
| Net Income | - | 6.64 | 13.38 | 22.56 | 29.58 |
| Net Income Common Stockholders | - | 6.64 | 13.38 | 22.56 | 29.58 |
| Net Income Including Noncontrolling Interests | - | 7.24 | 13.91 | 24.34 | 33.76 |
| Normalized Income | - | 12.32 | 13.43 | 22.03 | 28.84 |
| Diluted NI Availto Com Stockholders | - | 6.64 | 13.38 | 22.56 | 29.58 |
| Basic Average Shares | - | 29.06 | 29.86 | 31.19 | 34.56 |
| Diluted Average Shares | - | 30.16 | 30.19 | 32 | 35.32 |
| Reconciled Depreciation | - | 4.90 | 5.13 | 6.12 | 8.54 |
| Reconciled Cost Of Revenue | - | 414.66 | 477.86 | 601.48 | 817.20 |
| Total Unusual Items | - | -6.96 | -0.07 | 0.68 | 1 |
| Total Unusual Items Excluding Goodwill | - | -6.96 | -0.07 | 0.68 | 1 |
| Minority Interests | - | -0.60 | -0.53 | -1.78 | -4.19 |
| Special Income Charges | - | -6.96 | -0.07 | 0.68 | 1 |
| Depreciation Amortization Depletion Income Statement | - | 4.90 | 5.13 | 6.12 | 8.54 |
| Depreciation And Amortization In Income Statement | - | 4.90 | 5.13 | 6.12 | 8.54 |
| General And Administrative Expense | - | 33.98 | 36.67 | 50.21 | 71.08 |
| Other Gand A | - | 33.98 | 36.67 | 50.21 | 71.08 |
| Gain On Sale Of Ppe | - | -6.96 | -0.07 | 0.68 | 1 |
| Rent Expense Supplemental | - | 38.02 | 39.76 | 43.03 | 48.70 |
Healthcare sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| The Pennant Group, Inc.this co. | PNTG | $1.0B | 35.40↑ premium | 3.15 | 8.9% | 24.38 |
| Omada Health, Inc. | OMDA | $1.1B | -84.72 | 4.71 | -5.6% | -181.05 |
| Xeris Biopharma Holdings, Inc. | XERS | $1.1B | 1916.51 | 77.56 | 4.0% | 28.56 |
| Collegium Pharmaceutical, Inc. | COLL | $1.1B | 16.86 | 3.51 | 20.8% | 4.10 |
| CONMED Corporation | CNMD | $1.1B |
| - |
| - |
| - |
| - |
| - |
| 22.48 |
| 1.02 |
| 4.6% |
| 10.49 |
| Azenta, Inc. | AZTA | $1.1B | -18.88 | 0.61 | -3.2% | 20.85 |
| QuidelOrtho Corporation | QDEL | $1.0B | -0.92 | 0.54 | -58.9% | -7.68 |
| EyePoint, Inc. | EYPT | $1.0B | -4.43 | 3.36 | -75.8% | -4.13 |
| Artivion, Inc. | AORT | $1.0B | 103.65 | 2.26 | 2.2% | 18.87 |
| Peer Median | - | 7.97 | 2.81 | -0.5% | 7.30 | |